Global Active Pharmaceutical Ingredients (API) Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

  • receipt Report ID : 255922
  • calendar_today Published On: Jan, 2022
  • file_copy Pages: 156
  • list Chemical and Material
Buy @ $3500

The Active Pharmaceutical Ingredients (API) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest study, due to COVID-19 pandemic, the global Active Pharmaceutical Ingredients (API) market size is estimated to be worth US$ 74180 million in 2021 and is forecast to a readjusted size of USD 113880 million by 2028 with a CAGR of 6.3% during review period. CNS accounting for % of the Active Pharmaceutical Ingredients (API) global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Synthetic APIs segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Active Pharmaceutical Ingredients (API) include Teva, Mylan, DSM, Aurobindo Pharma, and Aspen, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Active Pharmaceutical Ingredients (API) market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Synthetic APIs

Biotech APIs

Market segment by Application can be divided into

CNS

Cardiovascular

Genitourinary/Hormonal Drugs

Respiratory

Rheumatology

Diabetes

Oncology

Others

The key market players for global Active Pharmaceutical Ingredients (API) market are listed below:

Teva

Mylan

DSM

Aurobindo Pharma

Aspen

Novartis

BASF

Pfizer

Huahai Pharmaceutical

Hisun Pharmaceutical

Sun Pharmaceutical Industries

Zhejiang Medicine

Dr. Reddy’s Laboratories

Zhejiang NHU

Bayer

NCPC

AbbVie

Shandong Xinhua Pharmaceutical

Northeast Pharm

Harbin Pharmaceutical

LKPC

Market segment by region, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Active Pharmaceutical Ingredients (API) product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Active Pharmaceutical Ingredients (API), with price, sales, revenue and global market share of Active Pharmaceutical Ingredients (API) from 2019 to 2022.

Chapter 3, the Active Pharmaceutical Ingredients (API) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Active Pharmaceutical Ingredients (API) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Active Pharmaceutical Ingredients (API) market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Active Pharmaceutical Ingredients (API).

Chapter 13, 14, and 15, to describe Active Pharmaceutical Ingredients (API) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Active Pharmaceutical Ingredients (API) Introduction

1.2 Market Analysis by Type

1.2.1 Overview: Global Active Pharmaceutical Ingredients (API) Revenue by Type: 2017 Versus 2021 Versus 2028

1.2.2 Synthetic APIs

1.2.3 Biotech APIs

1.3 Market Analysis by Application

1.3.1 Overview: Global Active Pharmaceutical Ingredients (API) Revenue by Application: 2017 Versus 2021 Versus 2028

1.3.2 CNS

1.3.3 Cardiovascular

1.3.4 Genitourinary/Hormonal Drugs

1.3.5 Respiratory

1.3.6 Rheumatology

1.3.7 Diabetes

1.3.8 Oncology

1.3.9 Others

1.4 Global Active Pharmaceutical Ingredients (API) Market Size & Forecast

1.4.1 Global Active Pharmaceutical Ingredients (API) Sales in Value (2017 & 2021 & 2028)

1.4.2 Global Active Pharmaceutical Ingredients (API) Sales in Volume (2017-2028)

1.4.3 Global Active Pharmaceutical Ingredients (API) Price (2017-2028)

1.5 Global Active Pharmaceutical Ingredients (API) Production Capacity Analysis

1.5.1 Global Active Pharmaceutical Ingredients (API) Total Production Capacity (2017-2028)

1.5.2 Global Active Pharmaceutical Ingredients (API) Production Capacity by Geographic Region

1.6 Market Drivers, Restraints and Trends

1.6.1 Active Pharmaceutical Ingredients (API) Market Drivers

1.6.2 Active Pharmaceutical Ingredients (API) Market Restraints

1.6.3 Active Pharmaceutical Ingredients (API) Trends Analysis

2 Manufacturers Profiles

2.1 Teva

2.1.1 Teva Details

2.1.2 Teva Major Business

2.1.3 Teva Active Pharmaceutical Ingredients (API) Product and Services

2.1.4 Teva Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.2 Mylan

2.2.1 Mylan Details

2.2.2 Mylan Major Business

2.2.3 Mylan Active Pharmaceutical Ingredients (API) Product and Services

2.2.4 Mylan Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.3 DSM

2.3.1 DSM Details

2.3.2 DSM Major Business

2.3.3 DSM Active Pharmaceutical Ingredients (API) Product and Services

2.3.4 DSM Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.4 Aurobindo Pharma

2.4.1 Aurobindo Pharma Details

2.4.2 Aurobindo Pharma Major Business

2.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product and Services

2.4.4 Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.5 Aspen

2.5.1 Aspen Details

2.5.2 Aspen Major Business

2.5.3 Aspen Active Pharmaceutical Ingredients (API) Product and Services

2.5.4 Aspen Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.6 Novartis

2.6.1 Novartis Details

2.6.2 Novartis Major Business

2.6.3 Novartis Active Pharmaceutical Ingredients (API) Product and Services

2.6.4 Novartis Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.7 BASF

2.7.1 BASF Details

2.7.2 BASF Major Business

2.7.3 BASF Active Pharmaceutical Ingredients (API) Product and Services

2.7.4 BASF Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.8 Pfizer

2.8.1 Pfizer Details

2.8.2 Pfizer Major Business

2.8.3 Pfizer Active Pharmaceutical Ingredients (API) Product and Services

2.8.4 Pfizer Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.9 Huahai Pharmaceutical

2.9.1 Huahai Pharmaceutical Details

2.9.2 Huahai Pharmaceutical Major Business

2.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services

2.9.4 Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.10 Hisun Pharmaceutical

2.10.1 Hisun Pharmaceutical Details

2.10.2 Hisun Pharmaceutical Major Business

2.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services

2.10.4 Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.11 Sun Pharmaceutical Industries

2.11.1 Sun Pharmaceutical Industries Details

2.11.2 Sun Pharmaceutical Industries Major Business

2.11.3 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product and Services

2.11.4 Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.12 Zhejiang Medicine

2.12.1 Zhejiang Medicine Details

2.12.2 Zhejiang Medicine Major Business

2.12.3 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product and Services

2.12.4 Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.13 Dr. Reddy’s Laboratories

2.13.1 Dr. Reddy’s Laboratories Details

2.13.2 Dr. Reddy’s Laboratories Major Business

2.13.3 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product and Services

2.13.4 Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.14 Zhejiang NHU

2.14.1 Zhejiang NHU Details

2.14.2 Zhejiang NHU Major Business

2.14.3 Zhejiang NHU Active Pharmaceutical Ingredients (API) Product and Services

2.14.4 Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.15 Bayer

2.15.1 Bayer Details

2.15.2 Bayer Major Business

2.15.3 Bayer Active Pharmaceutical Ingredients (API) Product and Services

2.15.4 Bayer Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.16 NCPC

2.16.1 NCPC Details

2.16.2 NCPC Major Business

2.16.3 NCPC Active Pharmaceutical Ingredients (API) Product and Services

2.16.4 NCPC Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.17 AbbVie

2.17.1 AbbVie Details

2.17.2 AbbVie Major Business

2.17.3 AbbVie Active Pharmaceutical Ingredients (API) Product and Services

2.17.4 AbbVie Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.18 Shandong Xinhua Pharmaceutical

2.18.1 Shandong Xinhua Pharmaceutical Details

2.18.2 Shandong Xinhua Pharmaceutical Major Business

2.18.3 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services

2.18.4 Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.19 Northeast Pharm

2.19.1 Northeast Pharm Details

2.19.2 Northeast Pharm Major Business

2.19.3 Northeast Pharm Active Pharmaceutical Ingredients (API) Product and Services

2.19.4 Northeast Pharm Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.20 Harbin Pharmaceutical

2.20.1 Harbin Pharmaceutical Details

2.20.2 Harbin Pharmaceutical Major Business

2.20.3 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services

2.20.4 Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

2.21 LKPC

2.21.1 LKPC Details

2.21.2 LKPC Major Business

2.21.3 LKPC Active Pharmaceutical Ingredients (API) Product and Services

2.21.4 LKPC Active Pharmaceutical Ingredients (API) Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 Active Pharmaceutical Ingredients (API) Breakdown Data by Manufacturer

3.1 Global Active Pharmaceutical Ingredients (API) Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)

3.2 Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturer (2019, 2020, 2021, and 2022)

3.3 Key Manufacturer Market Position in Active Pharmaceutical Ingredients (API)

3.4 Market Concentration Rate

3.4.1 Top 3 Active Pharmaceutical Ingredients (API) Manufacturer Market Share in 2021

3.4.2 Top 6 Active Pharmaceutical Ingredients (API) Manufacturer Market Share in 2021

3.5 Global Active Pharmaceutical Ingredients (API) Production Capacity by Company: 2021 VS 2022

3.6 Manufacturer by Geography: Head Office and Active Pharmaceutical Ingredients (API) Production Site

3.7 New Entrant and Capacity Expansion Plans

3.8 Mergers & Acquisitions

4 Market Analysis by Region

4.1 Global Active Pharmaceutical Ingredients (API) Market Size by Region

4.1.1 Global Active Pharmaceutical Ingredients (API) Sales in Volume by Region (2017-2028)

4.1.2 Global Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2028)

4.2 North America Active Pharmaceutical Ingredients (API) Revenue (2017-2028)

4.3 Europe Active Pharmaceutical Ingredients (API) Revenue (2017-2028)

4.4 Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue (2017-2028)

4.5 South America Active Pharmaceutical Ingredients (API) Revenue (2017-2028)

4.6 Middle East and Africa Active Pharmaceutical Ingredients (API) Revenue (2017-2028)

5 Market Segment by Type

5.1 Global Active Pharmaceutical Ingredients (API) Sales in Volume by Type (2017-2028)

5.2 Global Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2028)

5.3 Global Active Pharmaceutical Ingredients (API) Price by Type (2017-2028)

6 Market Segment by Application

6.1 Global Active Pharmaceutical Ingredients (API) Sales in Volume by Application (2017-2028)

6.2 Global Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2028)

6.3 Global Active Pharmaceutical Ingredients (API) Price by Application (2017-2028)

7 North America by Country, by Type, and by Application

7.1 North America Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)

7.2 North America Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)

7.3 North America Active Pharmaceutical Ingredients (API) Market Size by Country

7.3.1 North America Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2017-2028)

7.3.2 North America Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2028)

7.3.3 United States Market Size and Forecast (2017-2028)

7.3.4 Canada Market Size and Forecast (2017-2028)

7.3.5 Mexico Market Size and Forecast (2017-2028)

8 Europe by Country, by Type, and by Application

8.1 Europe Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)

8.2 Europe Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)

8.3 Europe Active Pharmaceutical Ingredients (API) Market Size by Country

8.3.1 Europe Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2017-2028)

8.3.2 Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2028)

8.3.3 Germany Market Size and Forecast (2017-2028)

8.3.4 France Market Size and Forecast (2017-2028)

8.3.5 United Kingdom Market Size and Forecast (2017-2028)

8.3.6 Russia Market Size and Forecast (2017-2028)

8.3.7 Italy Market Size and Forecast (2017-2028)

9 Asia-Pacific by Region, by Type, and by Application

9.1 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)

9.2 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)

9.3 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size by Region

9.3.1 Asia-Pacific Active Pharmaceutical Ingredients (API) Sales in Volume by Region (2017-2028)

9.3.2 Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2028)

9.3.3 China Market Size and Forecast (2017-2028)

9.3.4 Japan Market Size and Forecast (2017-2028)

9.3.5 Korea Market Size and Forecast (2017-2028)

9.3.6 India Market Size and Forecast (2017-2028)

9.3.7 Southeast Asia Market Size and Forecast (2017-2028)

9.3.8 Australia Market Size and Forecast (2017-2028)

10 South America by Region, by Type, and by Application

10.1 South America Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)

10.2 South America Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)

10.3 South America Active Pharmaceutical Ingredients (API) Market Size by Country

10.3.1 South America Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2017-2028)

10.3.2 South America Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2028)

10.3.3 Brazil Market Size and Forecast (2017-2028)

10.3.4 Argentina Market Size and Forecast (2017-2028)

11 Middle East & Africa by Country, by Type, and by Application

11.1 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Type (2017-2028)

11.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Application (2017-2028)

11.3 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size by Country

11.3.1 Middle East & Africa Active Pharmaceutical Ingredients (API) Sales in Volume by Country (2017-2028)

11.3.2 Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2028)

11.3.3 Turkey Market Size and Forecast (2017-2028)

11.3.4 Egypt Market Size and Forecast (2017-2028)

11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)

11.3.6 South Africa Market Size and Forecast (2017-2028)

12 Raw Material and Industry Chain

12.1 Raw Material of Active Pharmaceutical Ingredients (API) and Key Manufacturers

12.2 Manufacturing Costs Percentage of Active Pharmaceutical Ingredients (API)

12.3 Active Pharmaceutical Ingredients (API) Production Process

12.4 Active Pharmaceutical Ingredients (API) Industrial Chain

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.2 Active Pharmaceutical Ingredients (API) Typical Distributors

13.3 Active Pharmaceutical Ingredients (API) Typical Customers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Research Process and Data Source

15.3 Disclaimer

List of Tables

Table 1. Global Active Pharmaceutical Ingredients (API) Revenue by Type, (USD Million), 2017 & 2021 & 2028

Table 2. Global Active Pharmaceutical Ingredients (API) Revenue by Application, (USD Million), 2017 & 2021 & 2028

Table 3. Teva Basic Information, Manufacturing Base and Competitors

Table 4. Teva Major Business

Table 5. Teva Active Pharmaceutical Ingredients (API) Product and Services

Table 6. Teva Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 7. Mylan Basic Information, Manufacturing Base and Competitors

Table 8. Mylan Major Business

Table 9. Mylan Active Pharmaceutical Ingredients (API) Product and Services

Table 10. Mylan Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 11. DSM Basic Information, Manufacturing Base and Competitors

Table 12. DSM Major Business

Table 13. DSM Active Pharmaceutical Ingredients (API) Product and Services

Table 14. DSM Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 15. Aurobindo Pharma Basic Information, Manufacturing Base and Competitors

Table 16. Aurobindo Pharma Major Business

Table 17. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Product and Services

Table 18. Aurobindo Pharma Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 19. Aspen Basic Information, Manufacturing Base and Competitors

Table 20. Aspen Major Business

Table 21. Aspen Active Pharmaceutical Ingredients (API) Product and Services

Table 22. Aspen Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 23. Novartis Basic Information, Manufacturing Base and Competitors

Table 24. Novartis Major Business

Table 25. Novartis Active Pharmaceutical Ingredients (API) Product and Services

Table 26. Novartis Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 27. BASF Basic Information, Manufacturing Base and Competitors

Table 28. BASF Major Business

Table 29. BASF Active Pharmaceutical Ingredients (API) Product and Services

Table 30. BASF Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 31. Pfizer Basic Information, Manufacturing Base and Competitors

Table 32. Pfizer Major Business

Table 33. Pfizer Active Pharmaceutical Ingredients (API) Product and Services

Table 34. Pfizer Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 35. Huahai Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 36. Huahai Pharmaceutical Major Business

Table 37. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services

Table 38. Huahai Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 39. Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 40. Hisun Pharmaceutical Major Business

Table 41. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services

Table 42. Hisun Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 43. Sun Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors

Table 44. Sun Pharmaceutical Industries Major Business

Table 45. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Product and Services

Table 46. Sun Pharmaceutical Industries Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 47. Zhejiang Medicine Basic Information, Manufacturing Base and Competitors

Table 48. Zhejiang Medicine Major Business

Table 49. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Product and Services

Table 50. Zhejiang Medicine Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 51. Dr. Reddy’s Laboratories Basic Information, Manufacturing Base and Competitors

Table 52. Dr. Reddy’s Laboratories Major Business

Table 53. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Product and Services

Table 54. Dr. Reddy’s Laboratories Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 55. Zhejiang NHU Basic Information, Manufacturing Base and Competitors

Table 56. Zhejiang NHU Major Business

Table 57. Zhejiang NHU Active Pharmaceutical Ingredients (API) Product and Services

Table 58. Zhejiang NHU Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 59. Bayer Basic Information, Manufacturing Base and Competitors

Table 60. Bayer Major Business

Table 61. Bayer Active Pharmaceutical Ingredients (API) Product and Services

Table 62. Bayer Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 63. NCPC Basic Information, Manufacturing Base and Competitors

Table 64. NCPC Major Business

Table 65. NCPC Active Pharmaceutical Ingredients (API) Product and Services

Table 66. NCPC Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 67. AbbVie Basic Information, Manufacturing Base and Competitors

Table 68. AbbVie Major Business

Table 69. AbbVie Active Pharmaceutical Ingredients (API) Product and Services

Table 70. AbbVie Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 71. Shandong Xinhua Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 72. Shandong Xinhua Pharmaceutical Major Business

Table 73. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services

Table 74. Shandong Xinhua Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 75. Northeast Pharm Basic Information, Manufacturing Base and Competitors

Table 76. Northeast Pharm Major Business

Table 77. Northeast Pharm Active Pharmaceutical Ingredients (API) Product and Services

Table 78. Northeast Pharm Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 79. Harbin Pharmaceutical Basic Information, Manufacturing Base and Competitors

Table 80. Harbin Pharmaceutical Major Business

Table 81. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Product and Services

Table 82. Harbin Pharmaceutical Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 83. LKPC Basic Information, Manufacturing Base and Competitors

Table 84. LKPC Major Business

Table 85. LKPC Active Pharmaceutical Ingredients (API) Product and Services

Table 86. LKPC Active Pharmaceutical Ingredients (API) Sales (Tons), Price (USD/Ton), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)

Table 87. Global Active Pharmaceutical Ingredients (API) Sales by Manufacturer (2019, 2020, 2021, and 2022) & (Tons)

Table 88. Global Active Pharmaceutical Ingredients (API) Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)

Table 89. Market Position of Manufacturers in Active Pharmaceutical Ingredients (API), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021

Table 90. Global Active Pharmaceutical Ingredients (API) Production Capacity by Company, (Tons): 2020 VS 2021

Table 91. Head Office and Active Pharmaceutical Ingredients (API) Production Site of Key Manufacturer

Table 92. Active Pharmaceutical Ingredients (API) New Entrant and Capacity Expansion Plans

Table 93. Active Pharmaceutical Ingredients (API) Mergers & Acquisitions in the Past Five Years

Table 94. Global Active Pharmaceutical Ingredients (API) Sales by Region (2017-2022) & (Tons)

Table 95. Global Active Pharmaceutical Ingredients (API) Sales by Region (2023-2028) & (Tons)

Table 96. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2022) & (USD Million)

Table 97. Global Active Pharmaceutical Ingredients (API) Revenue by Region (2023-2028) & (USD Million)

Table 98. Global Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (Tons)

Table 99. Global Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (Tons)

Table 100. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2017-2022) & (USD Million)

Table 101. Global Active Pharmaceutical Ingredients (API) Revenue by Type (2023-2028) & (USD Million)

Table 102. Global Active Pharmaceutical Ingredients (API) Price by Type (2017-2022) & (USD/Ton)

Table 103. Global Active Pharmaceutical Ingredients (API) Price by Type (2023-2028) & (USD/Ton)

Table 104. Global Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (Tons)

Table 105. Global Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (Tons)

Table 106. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2017-2022) & (USD Million)

Table 107. Global Active Pharmaceutical Ingredients (API) Revenue by Application (2023-2028) & (USD Million)

Table 108. Global Active Pharmaceutical Ingredients (API) Price by Application (2017-2022) & (USD/Ton)

Table 109. Global Active Pharmaceutical Ingredients (API) Price by Application (2023-2028) & (USD/Ton)

Table 110. North America Active Pharmaceutical Ingredients (API) Sales by Country (2017-2022) & (Tons)

Table 111. North America Active Pharmaceutical Ingredients (API) Sales by Country (2023-2028) & (Tons)

Table 112. North America Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2022) & (USD Million)

Table 113. North America Active Pharmaceutical Ingredients (API) Revenue by Country (2023-2028) & (USD Million)

Table 114. North America Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (Tons)

Table 115. North America Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (Tons)

Table 116. North America Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (Tons)

Table 117. North America Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (Tons)

Table 118. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2017-2022) & (Tons)

Table 119. Europe Active Pharmaceutical Ingredients (API) Sales by Country (2023-2028) & (Tons)

Table 120. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2022) & (USD Million)

Table 121. Europe Active Pharmaceutical Ingredients (API) Revenue by Country (2023-2028) & (USD Million)

Table 122. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (Tons)

Table 123. Europe Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (Tons)

Table 124. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (Tons)

Table 125. Europe Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (Tons)

Table 126. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2017-2022) & (Tons)

Table 127. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Region (2023-2028) & (Tons)

Table 128. Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2022) & (USD Million)

Table 129. Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue by Region (2023-2028) & (USD Million)

Table 130. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (Tons)

Table 131. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (Tons)

Table 132. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (Tons)

Table 133. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (Tons)

Table 134. South America Active Pharmaceutical Ingredients (API) Sales by Country (2017-2022) & (Tons)

Table 135. South America Active Pharmaceutical Ingredients (API) Sales by Country (2023-2028) & (Tons)

Table 136. South America Active Pharmaceutical Ingredients (API) Revenue by Country (2017-2022) & (USD Million)

Table 137. South America Active Pharmaceutical Ingredients (API) Revenue by Country (2023-2028) & (USD Million)

Table 138. South America Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (Tons)

Table 139. South America Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (Tons)

Table 140. South America Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (Tons)

Table 141. South America Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (Tons)

Table 142. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Region (2017-2022) & (Tons)

Table 143. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Region (2023-2028) & (Tons)

Table 144. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue by Region (2017-2022) & (USD Million)

Table 145. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue by Region (2023-2028) & (USD Million)

Table 146. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Type (2017-2022) & (Tons)

Table 147. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Type (2023-2028) & (Tons)

Table 148. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Application (2017-2022) & (Tons)

Table 149. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales by Application (2023-2028) & (Tons)

Table 150. Active Pharmaceutical Ingredients (API) Raw Material

Table 151. Key Manufacturers of Active Pharmaceutical Ingredients (API) Raw Materials

Table 152. Direct Channel Pros & Cons

Table 153. Indirect Channel Pros & Cons

Table 154. Active Pharmaceutical Ingredients (API) Typical Distributors

Table 155. Active Pharmaceutical Ingredients (API) Typical Customers

List of Figures

Figure 1. Active Pharmaceutical Ingredients (API) Picture

Figure 2. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type in 2021

Figure 3. Synthetic APIs

Figure 4. Biotech APIs

Figure 5. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application in 2021

Figure 6. CNS

Figure 7. Cardiovascular

Figure 8. Genitourinary/Hormonal Drugs

Figure 9. Respiratory

Figure 10. Rheumatology

Figure 11. Diabetes

Figure 12. Oncology

Figure 13. Others

Figure 14. Global Active Pharmaceutical Ingredients (API) Revenue, (USD Million) & (Tons): 2017 & 2021 & 2028

Figure 15. Global Active Pharmaceutical Ingredients (API) Revenue and Forecast (2017-2028) & (USD Million)

Figure 16. Global Active Pharmaceutical Ingredients (API) Sales (2017-2028) & (Tons)

Figure 17. Global Active Pharmaceutical Ingredients (API) Price (2017-2028) & (USD/Ton)

Figure 18. Global Active Pharmaceutical Ingredients (API) Production Capacity (2017-2028) & (Tons)

Figure 19. Global Active Pharmaceutical Ingredients (API) Production Capacity by Geographic Region: 2022 VS 2028

Figure 20. Active Pharmaceutical Ingredients (API) Market Drivers

Figure 21. Active Pharmaceutical Ingredients (API) Market Restraints

Figure 22. Active Pharmaceutical Ingredients (API) Market Trends

Figure 23. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturer in 2021

Figure 24. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Manufacturer in 2021

Figure 25. Active Pharmaceutical Ingredients (API) Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021

Figure 26. Top 3 Active Pharmaceutical Ingredients (API) Manufacturer (Revenue) Market Share in 2021

Figure 27. Top 6 Active Pharmaceutical Ingredients (API) Manufacturer (Revenue) Market Share in 2021

Figure 28. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2017-2028)

Figure 29. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2017-2028)

Figure 30. North America Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (USD Million)

Figure 31. Europe Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (USD Million)

Figure 32. Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (USD Million)

Figure 33. South America Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (USD Million)

Figure 34. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue (2017-2028) & (USD Million)

Figure 35. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)

Figure 36. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2017-2028)

Figure 37. Global Active Pharmaceutical Ingredients (API) Price by Type (2017-2028) & (USD/Ton)

Figure 38. Global Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)

Figure 39. Global Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2017-2028)

Figure 40. Global Active Pharmaceutical Ingredients (API) Price by Application (2017-2028) & (USD/Ton)

Figure 41. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)

Figure 42. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)

Figure 43. North America Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2017-2028)

Figure 44. North America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2017-2028)

Figure 45. United States Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 46. Canada Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 47. Mexico Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 48. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)

Figure 49. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)

Figure 50. Europe Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2017-2028)

Figure 51. Europe Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2017-2028)

Figure 52. Germany Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 53. France Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 54. United Kingdom Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 55. Russia Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 56. Italy Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 57. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2017-2028)

Figure 58. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)

Figure 59. Asia-Pacific Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2017-2028)

Figure 60. Asia-Pacific Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2017-2028)

Figure 61. China Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 62. Japan Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 63. Korea Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 64. India Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 65. Southeast Asia Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 66. Australia Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 67. South America Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)

Figure 68. South America Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)

Figure 69. South America Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2017-2028)

Figure 70. South America Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2017-2028)

Figure 71. Brazil Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 72. Argentina Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 73. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2017-2028)

Figure 74. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2017-2028)

Figure 75. Middle East & Africa Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2017-2028)

Figure 76. Middle East & Africa Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2017-2028)

Figure 77. Turkey Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 78. Egypt Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 79. Saudi Arabia Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 80. South Africa Active Pharmaceutical Ingredients (API) Revenue and Growth Rate (2017-2028) & (USD Million)

Figure 81. Manufacturing Cost Structure Analysis of Active Pharmaceutical Ingredients (API) in 2021

Figure 82. Manufacturing Process Analysis of Active Pharmaceutical Ingredients (API)

Figure 83. Active Pharmaceutical Ingredients (API) Industrial Chain

Figure 84. Sales Channel: Direct Channel vs Indirect Channel

Figure 85. Methodology

Figure 86. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz